
40.43 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 23.28 Today|||52-Week Range 61.29 | -22.16% Year-to-Date |
Zentalis Pharmaceuticals Inc (ZNTL) President & CEO Anthony Y Sun Sold $2.8 million of Shares Apr 07 / GuruFocus News - Paid Partner Content | Zentalis Pharmaceuticals Inc (ZNTL) COO Kevin D. Bunker Sold $1.1 million of Shares Apr 06 / GuruFocus News - Paid Partner Content |
Previous close | 37.41 |
Today’s open | 42.74 |
Day’s range | 39.00 - 42.74 |
Volume | 37,782 |
Average volume (3 months) | 354,969 |
Market cap | $1.5B |
Earnings growth (last year) | -116.74% |
Earnings growth (this year) | -- |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | -100.00% |
P/E ratio | NM |
Price/Sales | -- |
Price/Book | -- |
No competitors data available. |
Next reporting date | May 14, 2021 |
EPS forecast (this quarter) | -$1.03 |
Annual revenue (last year) | $0.00 |
Annual profit (last year) | -$45.7M |
Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |